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Abstract
In vitro and in vivo experiments were conducted for the purpose to determine whether or not
the antitumor factor found in the regional lymph node cells of the mouse sensitized with Ehrlich
tumor cells would transfer its antitumor activity to normal lymph node cells. In in vivo exper-
iments normal lymph node cells incubated at 5◦C for 60 minutes in the supernatant containing
the antitumor activity have shown the antitumor activity against JTC-11 cells in mixed culture.
Namely, it hs been demonstrated that the antitumor activity in the supernatant can be transferred
directly to normal lymph node cells in vitro. In the in vitro experiments, the same results as in in
vivo experiments were obtained. The antitumor activity against JTC-11 cells has been detected in
the lymph node cells obtained on 4, 7 and 9 days after subcutaneous and intraperitoneal injections
of the supernatant having antitumor activity. Next, we tried DNase and RNase treatments of the
sensitized supernant to observe the transfer factor-like snbstance. The results indicate that, while
the passive transfer is possible with the supernatant treated with DNase, it is not with the RNase-
treated supernatant. From these findings it is assumed that the factor (in the sensitized supernatant)
capable of conferring the antitumor activity is an RNA-dependent substance (or a substance closely
associated with RNA) and is probably different from the antitumor factor reported in Parts 1 and
2.
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In our previous report we have already demonstrated that the sub-
cellular fraction (lOa, 000 g suprenatant) of the regional lymph node cells
from the mouse sensitized with Ehrlich ascites tumor cells contains an
antibody-like substance differing from the so-called humoral antibody. Ac-
cording to NAJARIAN and FELDMAN (1), it is possible to accomplish "passive
transfer" of transplantation immunity in vivo and in vitro with r-globulin-
like substance extracted from the sensitized lymph node cells at the time
of homotransplantation. In the present experiments we investigated to see
whether or not the subcellular factor (100, 000 g supernatant) extracted
from the regional lymph node cells after the transplantation of Ehrlich
cancer cells to mice would enable us to accomplish passive transfer in vitro
and in vivo. As a result we found that such a supernatant contains an
RNA-dependent substance probably different from the antibody-like sub-
stance that shows a direct antitumor activity, suggesting that this factor
acts like the transfer factor. The present report describes the results ob-
tained in this investigation.
MATERIALS AND METHODS
Animals: Just as in Part 1. Cb mice of inbred strain, two months old weigh-
ing about 21 g were used. These mice are bred and maintained at the Okayama
University Mouse Colony.
Tumor cells: The cells used were Ehrlich ascites tumor cells just as in Parts
1 and 2.
Culture cells: The cells were JTC-ll cells (derived from Ehrlich cancer cells)
and these cells are known to form tumors in mice.
Sensitization: Tumor cells (5 x 103 cells/ml) were transplanted subcutaneously
on the back between scapulas of Cb mice, 14 days after the transplantation
regional lymph nodes (from neck and axilla) were taken out, cut into small
pieces, washed with Hanks solution, homogenized, and the cell suspensions
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so prepared were used for the experiments.
Antitumorfactor: As the antitumor factor the supernatant fraction, F4, was
employed as in Part 1. This is prepared with the regional lymph node cells of
Cb mouse. Namely, these lymph node cells were homogenized in the glass homo-
genizer of Potter-Elevehjem, the homogenates were subjected to ultracentrifuga-
tion (Hitachi Ultracentrifuge) at 100,000 g for 60 minutes and the supernatant
thus obtained served as F4• This supernatant (as already reported in Part 1) has
antitumor activity on JTC-II cells.
Experimentals
1) In vitro passive transfer
Twelve Cb mice are sensitized with Ehrlich ascites tumor cells, 14 days later
the regional lymph nodes are taken out and homogenates are prepared as men-
tioned in the foregoing, and the homogenates are centrifuged at 100,000 g to
obtain the supernatant fraction. This fraction is kept at 5°C to be used for the
experiments.
Next, from 6 normal Cb mice both axillary and cervical lymph nodes are
removed, cut into small pieces in cold Hanks solution, these pieces are passed
through 150.mesh filter, washed well to remove serum, kept at 5°C to be used
as the control normal lymph node cells. By Eosin-Y staining it has been proven
that about 90% of these cells are alive.
To 3 ml of the supernatant prepared as described above (corresponding to 3
senstized mice) is added 7.5 X 105 cells/ml of normal lymph node cells and the the
mixture is incubated at 5°C for 60 minutes, while shaking the test tubes every
ten minutes. After incubation, the material is centrifuged at 1,5000 rpm, by
discarding the supernatant, the sediment is washed with Hanks solution 3 times,
and these cells are cultured with JTC-II cells.
2) In vivo passive transfer
The animals, tumor cells and culture medium used are the same as in the in
vitro experiments. For the antitumor factor, 100, 000 g supernatant of the sensiti.
zed mouse regional lymph node cells is used.
To 6 Cb mice 1.5 ml each of the sensitized supernatant is injected subcuta-
neouslyon the back and intraperitoneally to the total of 3 ml (equivalent to 3
sensitized mice). Four, 7 and 9 days after the injection, 2 mice each are sacrific-
ed, the regional lymph nodes are taken out, these are cut into small pieces, wa-
shed, passed through the ISO-mesh filter, and the filtrates so prepared served as
"supernatant-treated lymph node cells". With these lymph node cells and JTC-II
cells the mixed tissue culture is carried out.
3) In vivo passive transfer by the supernatant treated with DNase or RNase
By mixing the sensitized supernatant with 0.1 mg/ml DNase and incubating
the mixture at 37°C for two hours, 1.5 ml each of the incubated mixture is injec-
ted subcutaneously on the back and intraperitoneally to normal Cb mice. Nine
days after the injection, regional lymph nodes are removed from the animals,
2
Acta Medica Okayama, Vol. 23 [1969], Iss. 4, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol23/iss4/4
Antitumor Factors of Mouse. Lymph Node Cells 285
and these lymph nodes are treated in the same manner as with the in vivo passive
transfer and the cell suspension is prepared with Hanks solution, and this cell
suspension is mixed with JTC-ll cells and cultured for 24 or 48 hours at 37°C.
In the case of RNase treatment the identical procedures are carried out.
The control groups for these experiments are prepared in exactly the same
manner as in the in vivo passive transfer.
Tissue culture: As in Part 1 01) JTC-II cells are used as the culture cells.
1) In vitro passive transfer
To 10 mi medium 20, 000 cells/ml JTC-ll cells and 7.5 x lab cells/ml of the
sensitized lymph node cells are added, and 1.5 ml each of the mixture is put into
individual test tubes, lanted at an angle of 5° and incubated at 37°C for 24 or 48
hours. The medium used is consisted of the mixture of YLE solution and inac-
tivated bovine serum (8 : 2, vIv).
2) In vivo pa:.sive transfer
The mixture of 20, 000 cells/ml of JTC-ll cells and 2x 106 cells/ml of treated
lymph node cells is put into 10 ml medium. Next, 1.5 ml each of this mixture is
placed in short text tubes, and the stationary culture is conducted at 37°C for 24
or 48 hours.
3) ln vivo passive transfer with the supernatant treated with DNase or RNase
Culture methods employed in this experiment are identical with those used
in the in vitro passive transfer.
RESULTS
The in vitro passive transfer, in con·
trast to that of the controls, shows the
inhibitory effect on the growth of cuI.
ture cells within 24-hour culture as
shown in Fig. I, and by 48-hour culture
it reveals a marked difference from the
control. It is obvious that the sensitized
supernatant contained a substance cap.
able of transferring the antitumor
activity in vitro to normal lymph node
cells.
In the case of in vivo passive trans-
fer, the regional mouse lymph node cells
4 days after the injection of the super.
natant show no difference from the
control. With those lymph node cells
obtained 7 days after the supernatant
20,
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Fig. 1. In vitro Passive Transfer
I) control, ony JTC-II. 2) Effect of
normal Iymphnoce cells treated with
supernatant without antitumor activity
on JTC.II cells. 3) Effect of normal
lymph node cells after treatment with
the supernatant having antiturr.or ac-
tivity Oil JTC-II cells.
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injection, the sensitized group shows clearly the growth-inhibitory activity
by 24-hour culture, but by 48-hour culture there is no difference from the
control as shown in Fig. 2. With those lymph node cells obtained 9 days
after the injection, although culture conditons are not so good, both at
24- and 48-hour cultures they exhibit some growth inhibitory effect as
compared with the controls (Fig. 2), proving that passive transfer of anti-
tumor activity is accomplished.
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Fig. 2. In vivo Passive Transfer I) control, only JTC-I 1. 2) Effect of regional
lymph node cells from the mouse injected with the supernatant without antitumor
activity on JTC-II cells. 3) Effect of regional lymph node cells from the mouse
injected with the supernatant having antitumor activity on JTC-II cells.
As for passive transfer by the DNase treatment of the supernatant
(Fig. 3), the antitumor activity both at the 24-hour and 48-hour cultures
differs significantly from that of the controls, indicating that DNase has
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Fig. 3. In Vivo Passive Transfer
(after treating the supernatant with
DNase) The procedures in 2), and 3)
are identical with 2), and 3) in Fig. 2.
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Fig. 4. In Vivo Passive Transfer
(after treating supernant with RNase)
The procedures in I), 2) and 3) are
identical with those in Fig. 2.
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had not any effect on a transfer factor-like substance in the sensitized
supernatant. On the other hand, in the case where the supernatant is
treated with RNase, at 24-hour culture there is no difference from the
controls as illustrated in Fig. 4, whereas at 48-hour culture the sensitized
group, on the contrary, shows a slight proliferation as compared with the
normal control. It is evident that RNase acts on the transfer-like substance
of the sensitized supernatant as to nullify its transfer capacity.
DISCUSSION
As so far described, we have demonstrated that both in vitro and in
vivo the subcellular fraction (lOa, 000 g supernatant) of the regional lymph
node cells from the mouse transplanted with Ehrlich cancer cells contains
a substance that might be called "transfer factor" of LAWRENCE (8). Now,
there arises a question what this substance really would be. When this
supernrtant is mixed with normal lymph node cells and incubated, there
appears antitumor activity in the cells or when the supernatant is first
injected into the mouse, and the regional lymph node cells taken at certain
time intervals from the injected mice are made to act on JTC-II cells,
there can also be seen growth-inhibition of JTC-II cells.
Recently, it is being clarified that RNA and ribosomes play an impor-
tant role as the mediator in immune reaction. In the field of transplanta-
tion immunity likewise MANNICK and EGDAHL (2) have observed transfer
reaction with RNA treatment. That is. when RNA extracted from the
regional lymph node cells of the rabbit B transplanted with rabbit C skin
is incubated with the lymph node cells of the another rabbit A at 37°C for
15 minutes, then the RNA-treated lymph node cells are injected subcuta.
neously into the rabbit C, 2 to 3 days later there develops reddish swelling.
This result indicates that the extracted RNA containes the transfer factor-
like substance. Later MANNICK (3) has demonstrated that transfer immu-
nity could be conferred to the normal rabbits previously injected with
sensitized lymph node whole cells. By the homograft experiments with
mice GERL'GHTY and coworkers (4) have observed in vitro transfer immunity
of ribosomes. Namely, when the ribosomes from the spleen cells of the
BALBlc mouse transplanted with L cells (derived from CgH mouse) are
incubated with normal BALBlc mouse spleen cells, these normal spleen
cells acquire cytotoxic activity to destroy L cells in mixed culture. When
ribosomes are previously treated with RNase, it is said that transfer acti-
vity can be eliminated. Similar findings have been observed in vitro with
rats by WILSON and WECKER (5). In the field of microbiology and virology
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also there are reports stating that RNA.dependent antigen complex of
phagocytes can be transferred to lymphocytes and these lymphocytes ac-
quire immunity.
The transfer factor-like substance in the 100, 000 g supernatant in this
experiment is inactivated by RNase but not by DNase. Therefore, this
substance seems to be an RNA.dependent factor.
On the other hand, LAWRENCE (7, 8) has obtained an extract from
the Ieucocytes of a person showing delayed hypersensitivity, which imparts
the same type of hypersensitivity when it is injected to another person not
showing hypersensitivity, and he calls the active component of the extract
as "transfer factor". This transfer factor is not desensitized by DNase or
RNase nor by DNase plus trypsin treatment, and its real nature seems to
be still obscure. POWELL and coworkers (9) have also found a transfer
factor.like substance. They obtained regional lymphoid cells 11 to 50 days
after the transplantation of guinea pig skin homografts, subjected these
lymphoid cells to freezing-thawing repeatedly 10 times, then centrifuged
at 105, OOOg, the 105, OOOg supernatant thus obtained was dialyzed against
distilled water, and they found the sediment to contain a transfer factor.
This transfer factor.like substance has very interesting properties in that
it is not at all affected by DNase while its activity is rather increased by
RNase, and it is inactivated by trypsin. They consider arbitrarily the
essential component of this transfer factor.like substance to be protein.
This substance resembles quite closely the transfer factor of LAWRENCE
but it differs in that it loses its activity when treated with trypsin. In a
series of experiments with mice, NAJARIAN and FELDMAN (1) have noted a
transfer factor in sensitized lymhoid cells, which they consider to be quite
similar to r-globulin.
These transfer factor-like snbstances so far mentioned do not have a
uniform common property but these differences can accounted for the dif.
ferences in the species of animals and the methods of fractionations emp-
loyed. It remains a problem whether or not the transfer factor ovserved
by Lawrence, POWELL, and NAJARIAN-FELDMAN would transfer immunity
in vivo or in vitro. Moreover, this transfer factor mentioned by these three
groups of workers seems to be a protein-dependent substance and not an
RNA.dependent one. However, the transfer factor as proposed by MAN-
NICK and EGDAHL, GERUGHTY and coworkers, WILSON and WECKER, in.
cluding that observed in our experiments, seems to be an RNA-dependent
substance both in vitro and in vivo.
The question from what cell in regional lymph node the transfer
factor is derived and what is the pathway by which normal lymph node
6
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acquire immunity remains a problem to be solved in future. From the
fact that, although the trypsin-treated cells lose the direct activity on an·
tigens, they retain the potency for adoptive immunity as reported by
DAVID and coworkers (10) and others, the regional lymph node cells of
the mouse transplanted with Ehrlich cancer cells in the present experiment
seems to contain two kinds of substances; the one is a protein-dependent
cytophilic antibody-like substance that is inactivated by trypsin but wields
antitumor effect directly on target cells (11) and the other, which probably
has no direct effect, is an RNA-dependent substance that transforms nor-
mal lymphoid cells to sensitized lymphoid cells.
SUMMARY
In vitro and in vivo experiments were conducted for the purpose to
determine whether or not the antitumor factor found in the regional lymph
node cells of the mouse sensitized with Ehrlich tumor cells would transfer
its antitumor activity to normal lymph node cells.
In in vivo experiments normal lymph node cells incubated at 5°C for
60 minutes in the supernatant containing the antitumor activity have
shown the antitumor activity against JTC-II cells in mixed culture.
Namely, it hs been demonstrated that the antitumor activity in the super-
natant can be transferred directly to normal lymph node cells in vitro.
In the in vitro experiments, the same results as in in vivo experiments
were obtained. The antitumor activity against JTC-II cells has been
detected in the lymph node cells obtained on 4, 7 and 9 days after subcu-
taneous and intraperitoneal injections of the supernatant having antitumor
activity.
Next, we tried DNase and RNase treatments of the sensitized super-
nant to observe the transfer factor-like snbstance. The results indicate
that, while the passive transfer is possible with the supernatant treated
with DNase, it is not with the RNase-treated supernatant. From these
findings it is assumed that the factor (in the sensitized supernatant) capable
of conferring the antitumor activity is an RNA-dependent substance (or a
substance closely associated with RNA) and is probably different from the
antitumor factor reported in Parts 1 and 2.
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